Stock NOVUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Novus Therapeutics, Inc. Nasdaq

Equities

Chart calendar Novus Therapeutics, Inc.

2f42da7fc80.CsS7a89xHDzQ5GExbdD-41qh36ogrs_lzsLfV0AxOww.f4nwHq0pRHiboTkGJKefkQX-nZ1IwYy_noy0YCx7aEpnreMpjhx_C-OcMA~7f3f6fea645b98a3db3755dc47bb84ee

Upcoming events on Novus Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on Novus Therapeutics, Inc.

2024-04-17 01:00 pm Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-03-28 04:01 pm Q4 2023 Earnings Release
2023-12-04 05:00 pm Noble Capital Markets Emerging Growth Equity Conference
2023-12-04 12:00 pm Noble Capital Markets Emerging Growth Equity Conference
2023-11-16 03:00 am Jefferies London Healthcare Conference
2023-11-09 04:01 pm Q3 2023 Earnings Release
2023-11-02 10:00 am American Society of Nephrology Kidney Conference - Poster No - TH-PO835
2023-09-27 08:00 am Cantor Global Healthcare Conference - Panel
2023-08-10 07:00 am Q2 2023 Earnings Release
2023-06-21 02:30 pm Annual General Meeting
2023-06-09 09:00 am Jefferies Global Healthcare Conference
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:01 pm Q1 2023 Earnings Release
2023-04-01 05:00 am International Society of Nephrology World Congress - Poster No - SAT-188
2023-03-31 05:00 am International Society of Nephrology World Congress - Poster No - FRI-316
2023-03-30 04:30 pm Q4 2022 Earnings Call
2023-03-30 04:01 pm Q4 2022 Earnings Release
2023-02-15 05:00 pm SVB Securities Global Biopharma Conference
2022-11-14 04:30 pm Q3 2022 Earnings Call
2022-11-14 04:01 pm Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-12,9
-13,9
7.1%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-14,2
-15,3
7.29%		-18,5
-15,5
-19.26%		-36,9
-38,9
5.21%		-88,4
-41,4
-113.75%		-43,0
-44,9
4.28%
-56,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-16,0
-15,3
-4.65%		-23,2
-20,6
-12.51%		-36,9
-38,9
5.14%		-88,0
-41,3
-113.17%		-40,3
-42,8
5.78%
-55,1

Net income
Million USD		Released
Forecast
Spread 		-16,0
-15,3
-4.65%		-22,8
-20,5
-11.11%		-34,5
-39,0
11.49%		-88,0
-40,9
-115.02%		-40,3
-42,8
5.67%
-53,8

EPS
USD		Released
Forecast
Spread 		-24,5
-23,9
-2.26%		-15,7
-12,3
-27.75%		-2,33
-2,58
9.62%		-6,16
-2,75
-123.8%		-1,64
-1,77
7.43%
-1,45

Announcement Date17/03/2030/03/2124/03/2230/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-9,39
-11,6
18.86%		-9,86
-11,2
11.84%		-9,28
-11,3
17.99%		-10,6
-10,9
2.7%		-58,7
-11,5
-410.33%		-11,1
-11,0
-1%		-10,4
-11,4
9.05%		-11,2
-13,6
17.66%		-10,3
-12,2
15.03%
-12,8


-14,1


-14,6


-14,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,39
-11,5
18.63%		-9,86
-11,2
11.53%		-9,25
-11,3
18.18%		-10,5
-10,9
3.71%		-58,4
-11,5
-408.79%		-10,8
-11,0
1.85%		-9,58
-11,4
15.73%		-10,3
-45,9
77.46%		-9,63
-12,0
19.78%
-12,5


-13,8


-14,3


-14,5

Net income
Million USD		Released
Forecast
Spread 		-8,81
-12,1
27.07%		-9,86
-10,9
9.19%		-9,25
-11,1
16.7%		-10,5
-10,6
1.28%		-58,4
-11,2
-420.51%		-10,8
-10,7
-0.52%		-9,58
-11,4
15.61%		-10,3
-13,0
20.45%		-9,63
-12,0
19.62%
-11,9


-13,2


-13,5


-15,1

EPS
USD		Released
Forecast
Spread 		-0,60
-0,75
20%		-0,69
-0,68
-1.85%		-0,65
-0,70
7.67%		-0,73
-0,68
-7.35%		-4,09
-0,70
-482.21%		-0,75
-0,64
-17.8%		-0,40
-0,46
12.66%		-0,35
-0,46
23.91%		-0,29
-0,39
26.27%
-0,39


-0,39


-0,36


-0,35

Announcement Date24/03/2212/05/2211/08/2214/11/2230/03/2311/05/2310/08/2309/11/2328/03/24----

Upcoming sector events for Novus Therapeutics, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Novus Therapeutics, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. ELDN Stock
  4. Stock
  5. Calendar Novus Therapeutics, Inc.